Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression

NCT ID: NCT05480826

Last Updated: 2024-04-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-15

Study Completion Date

2028-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Genetic analyses conducted on patient with psychiatric disorders assessed at the expert centres resulted in the identific action of genetic variants associated with psychiatric disorders (Courtois, 2020). These data require further genetic and functional analyses. The first objective of this study is to investigate the disease-related inheritance of genetic variants in the families of individuals in whom these variants have been identified. The second objective is to explore the functional consequences of disease-associated genetic variants in patients cells and those of their relatives with and without these variants.

The present project aims to enrich existing biocollections with DNA from blood or saliva from relatives of patients identified with genetic variants. In addition, we wish to collect hair follicules from patients with identified genetic variants of interest and their family members who wish to participate in the study. These hair samples with SNA will be used to dedifferentiate the isolated cells into induced pluripotent stem cells (IPSCs), and then to differentiate them into cells expressing the gene of interest, such as neurons or astrocytes, or into more complex systems, such as brain organoids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychiatric Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

2 groups of subjects are enrolled in the study:

* patients with a mental disorder
* relatives of patients included
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Subject suffering from (according to DSM IV criteria)

* bipolar disorder
* unipolar depression
* schizophrenia
* autism spectrum disorder

Collection of hair follicle cells

Group Type OTHER

study of the transmission of genetic variants

Intervention Type GENETIC

the genetic variants of interest will be investigated by sequencing or genotyping on genomic DNA

Relatives

Relatives of enrolled patients suffering from psychiatric disorder.

* test to detect psychiatric disorders
* blood or saliva sampling for genomic DNA extraction
* Collection of hair follicle cells

Group Type OTHER

study of the transmission of genetic variants

Intervention Type GENETIC

the genetic variants of interest will be investigated by sequencing or genotyping on genomic DNA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

study of the transmission of genetic variants

the genetic variants of interest will be investigated by sequencing or genotyping on genomic DNA

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For patients:
* Subjects suffering from (according to DSM IV criteria) : Bipolar disorder, Unipolar depression, Schizophrenia, Autism spectrum disorder
* Age over 18 years
* Subject affiliated to the social security system
* Including patients under guardianship, curatorship,
* Patients included in the Fondation FondaMental cohort whose genetic analyses have revealed the need for comparative and functional genetic studies.
* Having signed the consent form

For relatives :

* Age over 18 years
* Relative of patient included in the Fondattion FondaMental cohort
* Including relative under guardianship, curatorship
* Having signed the consent
* Affiliated to social security

Exclusion Criteria

* For all subjects:
* Any condition that, in the opinion of the investigator, would make the subject's participation in the study undesirable or that would compromise compliance with the protocol
* Persons deprived of liberty
* Inability to understand French
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation FondaMental

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marion Leboyer, MD PhD

Role: STUDY_CHAIR

Fondation FondaMental

Stephane JAMAIN, PhD

Role: STUDY_DIRECTOR

Institut National de la Santé Et de la Recherche Médicale, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Albert Chenevier

Créteil, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stephane JAMAIN, PhD

Role: CONTACT

149813775 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Agnes PELLETIER, MD, PhD

Role: primary

01.49.81.30.51 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02551-40

Identifier Type: OTHER

Identifier Source: secondary_id

FF21-GENI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Psychiatric Genotype/Phenotype Project Repository
NCT00762866 ENROLLING_BY_INVITATION